At 48 weeks, the combined 8 mg Phase 2 groups had an estimated mean weight change of −22.8%. The paper also reports results for the placebo group and the other assigned amounts.
A Phase 2 comparison group
A combined estimate can summarize participants from groups that shared a target but differed in protocol details. The publication separates some results in its supplementary material.
How to interpret the evidence
Use the combined label when quoting the headline number and consult the original study when analyzing group design.
This series reports assigned research arms for interpreting study results. Retatrutide is investigational, and clinical-trial amounts are not dosing instructions.